This article was originally published in The Gray Sheet
Firm of Houlihan, Lokey, Howard & Zukin is engaged as financial advisor to the company Jan. 6 to "assist the company in identifying and evaluating its strategic alternatives" and "maximize the value" of the PapNet cytology technology
You may also be interested in...
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.